Definitive Healthcare (DH) Stock
Definitive Healthcare's price implies about -20% free cash flow growth a year.
Key numbers
- P/E (forward)
- 6.02x
- Revenue growth
- -6.2%
- Operating margin
- -105.4%
- Debt / equity
- 0.84x
What Definitive Healthcare's price implies
From a reverse DCF on Definitive Healthcare's SEC filings.
- Free cash flow, last 5 years
- 11.2%a year
- Revenue, same period
- 15.3%a year
At a market value of $123M, Definitive Healthcare's free cash flow of $37M (fiscal 2025) would need to grow about -20% a year for the stock to be worth today's price. That is slower than the company has grown its free cash flow over the last 5 years. A 9% discount rate and 3% growth after year 10 (how it works). Change them in the Modeling tab or the reverse DCF calculator.
Revenue and free cash flow
Fiscal years, from Definitive Healthcare's 10-K filings.
Definitive Healthcare revenue and free cash flow
FY2020–FY2025Results from SEC filings
All three statements · Quarters, TTM and 20+ years of statements in Investingly
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $166M | $223M | $251M | $252M | $242M |
| Net income | -$18M | -$7M | -$202M | -$413M | -$139M |
| Free cash flow | $18M | $27M | $38M | $46M | $37M |
| EPS (diluted) | -$0.19 | -$0.07 | -$1.79 | -$3.54 | -$1.30 |
| Operating margin | -16.4% | -19.8% | -131.2% | -281.8% | -92.9% |
Where the revenue comes from
By products, fiscal 2025. By year
Superinvestors who own DH
From each investor's latest 13F filing (what a 13F shows). All 7 holders
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| David Shaw D. E. Shaw & Co. | Trimmed | $2M | 0.00% | Q2 2026 |
| Cliff Asness AQR Capital Management | Added | $747,087 | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies | Added | $436,256 | 0.00% | Q2 2026 |
| Two Sigma Two Sigma Investments | Added | $423,201 | 0.0% | Q2 2026 |
| Arrowstreet Capital Arrowstreet Capital | Trimmed | $335,787 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management | Trimmed | $288,000 | 0.0% | Q3 2026 |
| Paul Marshall Marshall Wace | Added | $136,103 | 0.0% | Q2 2026 |
Definitive Healthcare insider buying
Open-market purchases by executives and directors in the last 12 months, from SEC Form 4 filings (what insider buying tells you).
No open-market insider purchases of DH in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.
Fundamental grade
Five factors scored 1 to 9 from DH's latest numbers. It describes the business, not whether the stock is a buy.
Get an alert at your buy price
Free accounts get 3 price alerts.
How Definitive Healthcare compares
Definitive Healthcare's P/FCF is higher than 5% of Healthcare companies and 12% of the 2,359 companies with a P/FCF figure.
| Higher than | Healthcare | All stocks |
|---|---|---|
| P/FCF | 5% | 12% |
| Revenue growth | 20% | 12% |
| Operating margin | 22% | 8% |
| ROE | 14% | 5% |
Questions about Definitive Healthcare
What growth does Definitive Healthcare's stock price imply?
At a market value of $123M, Definitive Healthcare would need its free cash flow to grow about -20% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 5 years its free cash flow grew 11% a year.
Are Definitive Healthcare insiders buying the stock?
No open-market insider purchases of DH in the last 12 months, according to SEC Form 4 filings.
Which superinvestors own Definitive Healthcare?
7 of the superinvestors Investingly tracks hold DH in their latest 13F, including David Shaw, Cliff Asness, Jim Simons.
Companies like Definitive Healthcare
LifeMD Inc (LFMD)$113MHealth Catalyst Inc (HCAT)$111MOptimizeRx Corp (OPRX)$165MAmerican Well Corp (AMWL)$204MSo-Young International Inc. (SY)$206MSpok Holdings Inc (SPOK)$246MOneMedNet Corp (ONMD)$297MClaritev Corporation (CTEV)$385MEvolent Health Inc (EVH)$518M All Healthcare stocks→Prices and ratios as of Nov 9, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.